Physiology of GIP(1-30)NH2 in Humans

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

August 23, 2018

Study Completion Date

June 9, 2019

Conditions
Glucose Metabolism Disorders
Interventions
OTHER

GIP(1-30)NH2

Intravenous administration of the peptide hormone GIP(1-30)NH2 during a stepwise glucose clamp

OTHER

GIP(1-42)

Intravenous administration of the peptide hormone GIP(1-42) during a stepwise glucose clamp

OTHER

Saline

Intravenous administration of saline during a stepwise glucose clamp

Trial Locations (1)

2900

Clinical Metabolic Physiology, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT04792762 - Physiology of GIP(1-30)NH2 in Humans | Biotech Hunter | Biotech Hunter